Visit type | ||
---|---|---|
Screening and treatment visit | Follow-up visita | |
Procedures: | Day 1 | Day 3 (± 1 day) |
Assessment of eligibility | X | |
Randomization | X | |
Study drug administration | X | |
Vital signsb | X | |
Complete physical exam | X | |
Routine laboratory testingc | X | |
ECG | X | |
RASSb | X | |
Time to sedation | X | |
Time to psychiatric assessment (in the ED) | X | |
Rescue medication assessmentb | X | |
Incidence of sedation outcomes | X | |
Use of physical restraints | X | |
Effectiveness of Study Drug Blinding Survey | X | |
Study Nurse Experience Survey | X | |
Participant Experience Survey | X | |
VAS | X | |
Barnes Akathisia Scale | X | |
GDS | X | |
Pre-hospital use of force | X | |
Adverse event collection | X | X |
Neuroleptic malignant syndrome | Xd | X |
Review participant information sheet | X |